Jason Baumgartner of BEKhealth Corporation Talks About The Current State of Research Operations in a COVID World with TrialSite
Jason CEO of BEKhealth Corporation talks with TrialSite about the current state of research operations in a COVID world. How COVID has impacted researcher capacity. How technology is improving patient pre-screening and enrollment. How sites can implement new technologies to alleviate manual processes and see more patients.
Read More
Why RWD-Informed Protocols Still Miss Enrollment Targets
Why RWD-Informed Protocols Still Miss Enrollment TargetsSponsors are using more RWD than ever, but enrollment is still failing 80% of the time. Here's why. The paradox sponsors keep running into RWD and clinical trial enrollment are increasingly discussed in the same...
First Analysis: Industry Forums Highlight 5 Key Themes in Pharma IT
Why “Eligible Patients” Aren’t Always Enrollable Patients
Why “Eligible Patients” Aren’t Always Enrollable PatientsThe industry’s reliance on eligibility as a proxy for enrollment is understandable. Protocols are built around eligibility criteria. Feasibility assessments often rely on structured EHR data and historical...
Why Traditional Feasibility Fails (and What Actually Predicts Enrollment Success)
Why Traditional Feasibility Fails (and What Actually Predicts Enrollment Success)Clinical trial feasibility is intended to answer a straightforward question: Can this study realistically enroll patients?Yet across therapeutic areas and trial phases, studies that pass...